시장보고서
상품코드
1488622

니코틴 껌 시장 : 용량 강도별, 플레이버별, 유통 채널별, 지역별, 기회, 예측(2017-2031년)

Nicotine Gum Market Assessment, By Dosage Strength [2mg, 4mg, Others], By Flavor [Flavored, Unflavored], By Distribution Channel [Online, Offline], By Region, Opportunities and Forecast, 2017-2031F

발행일: | 리서치사: Market Xcel - Markets and Data | 페이지 정보: 영문 224 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

세계 니코틴 껌 시장 규모는 2024-2031년 예측 기간 동안 5.82%의 CAGR로 2023년 17억 1,000만 달러에서 2031년 26억 9,000만 달러로 확대될 것으로 예상됩니다. 시장 성장에 기여하는 주요 요인은 소비자의 금연 지향성입니다. 각국의 다양한 정부의 노력과 재활센터 설립은 금연 운동에 더욱 박차를 가하고 있습니다. 미국 질병예방통제센터(CDC)의 조사에 따르면, 미국에서는 매년 약 2,830만 명의 성인이 담배를 피우고, 약 280만 명의 중고등학생이 최소 한 개비 이상의 담배 제품을 소비하고 있습니다. 미국 식품의약국은 니코틴 대체 요법을 지원하기 위해 니코틴 껌을 포함한 니코틴 기반 제품의 시판 허가를 승인했습니다.

흡연으로 인한 잠재적 건강 피해에 대한 소비자의 인식이 높아지면서 니코틴 껌과 같은 금연 보조 제품의 성장이 가속화되고 있습니다. 전통적인 흡연 대안을 찾는 소비자가 증가함에 따라 주요 기업들은 지속적으로 성장하는 시장에 자본을 투자하기 위한 이니셔티브를 취하고 있습니다.

또한, 담배와 흡연으로 인한 사망자 수의 증가는 시장 성장을 촉진하고 소비자를 니코틴 껌과 같은 금연 제품으로 점차 전환하고 있습니다. 이에 따라 제조업체는 다양한 유형의 소비자를 충족시키기 위해 다양한 맛의 새로운 니코틴 껌을 출시하도록 유도하고 있습니다. 소비자들은 담배 소비가 장애와 사망의 원인이라는 사실을 인식하게 되었으며, 이는 소비자를 이러한 제품으로 끌어들이고 있습니다.

니코틴 껌은 과거에는 틈새시장이었지만, 금연과 건강한 라이프스타일을 원하는 소비자에게 편리하고 안전한 선택이기 때문에 시장에서 그 중요성이 커지고 있습니다. 이에 따라 니코틴 껌에 대한 수요가 증가하며 성장세를 보이고 있습니다.

이 보고서는 세계 니코틴 껌 시장을 조사하여 시장 개요와 함께 용량 강도별, 플레이버별, 유통 채널별, 지역별 동향, 시장 진입 기업 개요 등을 제공합니다.

목차

제1장 조사 방법

제2장 프로젝트 범위와 정의

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 니코틴 껌 시장 전망, 2017-2031년

  • 시장 규모와 예측
  • 용량 강도별
  • 플레이버별
  • 유통 채널별
  • 지역별
  • 기업별 시장 점유율(%), 2023년

제6장 세계의 니코틴 껌 시장 전망, 지역별, 2017-2031년

  • 북미
  • 유럽
  • 아시아태평양
  • 남미
  • 중동 및 아프리카

제7장 시장 매핑, 2023년

제8장 거시적 환경과 산업 구조

  • 수요 공급 분석
  • 수출입 분석
  • 밸류체인 분석
  • PESTEL 분석
  • Porter's Five Forces 분석

제9장 시장 역학

제10장 주요 진출 기업 상황

제11장 가격 분석

제12장 사례 연구

제13장 주요 진출 기업 전망

  • Haleon PLC
  • Enorama Pharma AB
  • Perrigo Company PLC
  • Cipla Health Limited(Nicotex)
  • Philip Morris International Inc.(Fertin Pharma A/S)
  • Alchem International Pvt. Ltd.
  • Alkalon A/S
  • Swedish Match AB
  • Rogue Holdings, LLC
  • PL Developments, LLC

제14장 전략적 제안

제15장 문의와 면책사항

ksm 24.06.10

Global nicotine gum market is projected to witness a CAGR of 5.82% during the forecast period 2024-2031, growing from USD 1.71 billion in 2023 to USD 2.69 billion in 2031. The major driver which is contributing to the growth of the market is consumers' preference to quit smoking. Various governmental initiatives in different countries, along with the establishment of rehabilitation centers, are further supplementing the anti-smoking movement. According to a study conducted by the Centers for Disease Control and Prevention, in the U.S. each year, roughly 28.3 million adults smoke cigarettes, and around 2.8 million middle and high school students consume at least one tobacco product. To aid nicotine replacement therapies, the Food and Drug Administration of the U.S. approved over-the-counter sales of nicotine-based products, which include nicotine gums.

The rising awareness of consumers about potential health hazards associated with smoking has driven the growth of smoking cessation products such as nicotine gum. With a greater number of consumers seeking traditional smoking substitutes, key players are taking initiatives to capitalize on the ever-growing market.

Additionally, the increasing number of deaths due to tobacco and smoking are driving the growth of the market and making the consumers shift gradually towards cessation products like nicotine gums. This is inducing the manufacturers to launch new nicotine gums in different flavors to cater to different types of consumers. Consumers are becoming aware about tobacco consumption causing disability and deaths, which is attracting them more towards these products. As per Centers of Disease Control and Prevention, in the United States, around 0.5 million Americans encounter premature death annually due to smoking or exposure to passive smoke. Around 16 million get a serious illness due to smoking each year in the United States, resulting in an expenditure of over USD 225 billion on medical care to treat smoking-related diseases.

Nicotine gum, once a niche product, has gained relevance in the market as it is a convenient and safer option for consumers who prefer to quit smoking and lead a healthier lifestyle. This facilitates a rise in the demand for the product, leading to a growth trajectory.

Nicotine Replacement Therapy is Augmenting the Growth

The increase in usage of nicotine gums is helping consumers to resist smoking and consumption of tobacco. The increasing awareness of potential health hazards through the consumption of tobacco is facilitating the demand for nicotine gums.

Nicotine gum is a nicotine replacement therapy that helps consumers minimize their craving for smoking and enables them to quit it. They are most used by consumers to eliminate tobacco consumption. Nicotine gums are U.S. FDA-approved medicines to quit smoking that can be purchased over the counter, i.e., without the prescription of a doctor. As per the National Cancer Institute study, in 2022, 53% of adults in the United States attempted to quit smoking within a pear.

Nicotine replacement therapy, including nicotine gum, is fueling the market's growth by providing consumers with safer alternatives to tobacco and cigarettes. Nicotine replacement therapy products are witnessing a surge in demand as they offer a controlled release of nicotine, which helps consumers curb their urge to smoke. Thus, they facilitate the consumers' smoking cessation efforts, supplementing the market's growth.

Inclination Towards Healthier Lifestyles

Increasing consumer consciousness and awareness created by the social authorities have started to make people realize the ill-effects and harmful consequences of smoking, which has led to an increase in the number of quitters. The rising awareness in people is spreading rapidly due to the motivation to discontinue their habit of smoking and adopting a healthier lifestyle, which is driving the global nicotine market growth.

People are taking self-help challenges to quit smoking and are opting for quit coaches who guide and track improvements in people. Nicotine gums are being used by people on a daily basis, which drives market growth. As people see the benefits of quitting smoking and their scope of improvement, they are further motivated towards a cleaner lifestyle. The trend of nicotine gums has become famous among teenagers, who started smoking at a young age and later wish to quit. It is a fast-growing industry with a long product life cycle due to the important role it plays in the lives of people who are trying to quit smoking.

For instance, in March 2023, The North Carolina Department of Health and Human Services launched QuitlineNC with improved features it offers services and ways for tobacco users to successfully quit smoking. They have introduced the provision of adopting 'Quit Coaches' through live chats or texts for those who wish to quit smoking or using products such as e-cigarettes and vapes. It offers the option to watch videos of similar people, participate in help-groups and create a personalized dashboard to track their progress.

International Public Health Agencies Drive Market Growth

Since there is an alarming surge in several people who are affected by lung diseases and throat diseases due to smoking, healthcare governing agencies are focusing on ways to reduce the usage of tobacco and the number of people who have a habit of smoking. The concern is being addressed at a global level and is pushing the market for nicotine, which is the core ingredient in nicotine gum.

International agencies such as the World Health Organization have been proactively participating in the betterment of this therapeutic system, promoting the use of nicotine gums among smokers. They have introduced new ways for people who wish to quit smoking that are more effective and easier to apply daily. Hence, the use of nicotine gums that are easy to carry and consume is gaining traction in the market and driving growth.

In November 2021, WHO updated its model list, adding different therapeutic models that aid people in quitting smoking. Earlier, WHO focused more on therapies, but it has shifted towards supplying nicotine to people through other mediums, such as nicotine gums and patches, which are very effective and reduce nicotine withdrawal symptoms.

New Entrants to Increase Nicotine Gum Market Size

The entry of new manufacturers into the nicotine gum market significantly contributes to its growth. These manufacturers are entering the nicotine gum market for several reasons, which include the rising consumer' demand for nicotine replacement therapies and the prevalence of strategic opportunities.

Strict regulation of tobacco products by governmental bodies in different regions has prompted manufacturers to diversify their product portfolios. Nicotine gum offers consumers a tobacco-free solution for quitting smoking, allowing manufacturers to meet consumers' needs in alignment with public health initiatives.

Additionally, the nicotine gum market provides the opportunity for manufacturers to expand their existing product portfolios and capabilities. Various key players already have expertise in the pharmaceutical sector, healthcare domain, and consumer goods, making the manufacturing and distribution of nicotine gums a convenient extension of their business.

Additionally, the entrance of new manufacturers introduces a wider range of products for consumers, including different flavors, formulations, and strengths, enriching their experience.

For instance, in August 2023, Blip, a smoking cessation company, entered the market to sell its FDA-approved nicotine replacement therapy products, including nicotine gum. These nicotine gums have retro packaging, and the company delivers its products to consumers through both online and offline channels.

Future Market Scenario (2024 - 2031F)

The market is anticipated to grow with the rising collaborations among the key players, the entry of new manufacturers, and the latest product launches. Mergers and acquisitions play a pivotal role in fostering the growth of the nicotine gum market. Strategic partnerships facilitate market penetration, leverage synergies between manufacturers, and expand distribution channels. They open global opportunities for the manufacturers, enabling them to access new geographical regions and enter diverse consumer segments.

For instance, in 2024, Dr Reddy's Laboratories is expected to acquire Nicotinell, the second largest nicotine replacement therapy brand of Haleon PLC, which manufactures nicotine gums.

Key Players Landscape and Outlook

Key players in the market are helping the growth by focusing on continuous product innovation, retail expansions, and strategic marketing. The manufacturers are actively expanding their product portfolio, increasing their base of customers, and catering to their evolving needs.

Companies are working on their R&D for the betterment of their products as well as to be able to launch good products for their consumers. Also, by enhancing their R&D, companies establish good connections with other companies, get into partnerships, and sign mergers and acquisitions, leading to movement in the industry.

For instance, in July 2021, Philip Morris International Inc. signed the acquisition of Fertin Pharma, a nicotine gum maker, at a value of nearly 820 million dollars. Fertin Pharma makes products such as chewing gums and tablets that contain nicotine, helping people quit smoking.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Voice of Customer

  • 4.1.Demographics (Age/Cohort Analysis - Baby Boomers and Gen X, Millennials, Gen Z; Gender; Income - Low, Mid and High; Geography; Nationality; etc.)
  • 4.2.Product and Market Intelligence
  • 4.3.Mode of Brand Awareness
  • 4.4.Factors Considered in Purchase Decisions
    • 4.4.1.Effectiveness
    • 4.4.2.Product Variety and Range
    • 4.4.3.Innovation
    • 4.4.4.Price
    • 4.4.5.Availability and Accessibility
    • 4.4.6.Promotional Discounts
  • 4.5.Consideration of Privacy & Safety Regulations
  • 4.6.Purchase Channel
  • 4.7.Frequency of Purchase
  • 4.8.Existing or Intended User
  • 4.9.Recommendations from friends, family/online reviews
  • 4.10.Role of Brand Ambassador or Influencer Marketing on Product/Brand Absorption

5.Global Nicotine Gum Market Outlook, 2017-2031F

  • 5.1.Market Size & Forecast
    • 5.1.1.By Value
    • 5.1.2.By Volume
  • 5.2.By Dosage Strength
    • 5.2.1. 2mg
    • 5.2.2. 4mg
    • 5.2.3. Others
  • 5.3.By Flavor
    • 5.3.1.Flavored
    • 5.3.2.Unflavored
  • 5.4.By Distribution Channel
    • 5.4.1.Online
    • 5.4.2.Offline
      • 5.4.2.1.Supermarkets/Hypermarkets
      • 5.4.2.2.Convenience Stores
      • 5.4.2.3.Pharmacies
  • 5.5.By Region
    • 5.5.1.North America
    • 5.5.2.Europe
    • 5.5.3.Asia-Pacific
    • 5.5.4.South America
    • 5.5.5.Middle East and Africa
  • 5.6.By Company Market Share (%), 2023

6.Global Nicotine Gum Market Outlook, By Region, 2017-2031F

  • 6.1.North America*
    • 6.1.1.Market Size & Forecast
      • 6.1.1.1.By Value
      • 6.1.1.2.By Volume
    • 6.1.2.By Dosage Strength
      • 6.1.2.1.2mg
      • 6.1.2.2.4mg
      • 6.1.2.3.Others
    • 6.1.3.By Flavor
      • 6.1.3.1.Flavored
      • 6.1.3.2.Unflavored
    • 6.1.4.By Distribution Channel
      • 6.1.4.1.Online
      • 6.1.4.2.Offline
        • 6.1.4.2.1.Supermarkets/Hypermarkets
        • 6.1.4.2.2.Convenience Stores
        • 6.1.4.2.3.Pharmacies
    • 6.1.5.United States*
      • 6.1.5.1.Market Size & Forecast
        • 6.1.5.1.1.By Value
        • 6.1.5.1.2.By Volume
      • 6.1.5.2.By Dosage Strength
        • 6.1.5.2.1.2mg
        • 6.1.5.2.2.4mg
        • 6.1.5.2.3.Others
      • 6.1.5.3.By Flavor
        • 6.1.5.3.1.Flavored
        • 6.1.5.3.2.Unflavored
      • 6.1.5.4.By Distribution Channel
        • 6.1.5.4.1.Online
        • 6.1.5.4.2.Offline
          • 6.1.5.4.2.1.Supermarkets/Hypermarkets
          • 6.1.5.4.2.2.Convenience Stores
          • 6.1.5.4.2.3.Pharmacies
    • 6.1.6.Canada
    • 6.1.7.Mexico

All segments will be provided for all regions and countries covered

  • 6.2.Europe
    • 6.2.1.Germany
    • 6.2.2.France
    • 6.2.3.Italy
    • 6.2.4.United Kingdom
    • 6.2.5.Russia
    • 6.2.6.Netherlands
    • 6.2.7.Spain
    • 6.2.8.Turkey
    • 6.2.9.Poland
  • 6.3.Asia-Pacific
    • 6.3.1.India
    • 6.3.2.China
    • 6.3.3.Japan
    • 6.3.4.Australia
    • 6.3.5.Vietnam
    • 6.3.6.South Korea
    • 6.3.7.Indonesia
    • 6.3.8.Philippines
  • 6.4.South America
    • 6.4.1.Brazil
    • 6.4.2.Argentina
  • 6.5.Middle East & Africa
    • 6.5.1.Saudi Arabia
    • 6.5.2.UAE
    • 6.5.3.South Africa

7.Market Mapping, 2023

  • 7.1.By Dosage Strength
  • 7.2.By Flavor
  • 7.3.By Distribution Channel
  • 7.4.By Region

8.Macro Environment and Industry Structure

  • 8.1.Demand Supply Analysis
  • 8.2.Import Export Analysis
  • 8.3.Value Chain Analysis
  • 8.4.PESTEL Analysis
    • 8.4.1.Political Factors
    • 8.4.2.Economic System
    • 8.4.3.Social Implications
    • 8.4.4.Technological Advancements
    • 8.4.5.Environmental Impacts
    • 8.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 8.5.Porter's Five Forces Analysis
    • 8.5.1.Supplier Power
    • 8.5.2.Buyer Power
    • 8.5.3.Substitution Threat
    • 8.5.4.Threat from New Entrant
    • 8.5.5.Competitive Rivalry

9.Market Dynamics

  • 9.1.Growth Drivers
  • 9.2.Growth Inhibitors (Challenges and Restraints)

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)
  • 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.Haleon PLC
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products & Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus & Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.Enorama Pharma AB
  • 13.3.Perrigo Company PLC
  • 13.4.Cipla Health Limited (Nicotex)
  • 13.5.Philip Morris International Inc. (Fertin Pharma A/S)
  • 13.6.Alchem International Pvt. Ltd.
  • 13.7.Alkalon A/S
  • 13.8.Swedish Match AB
  • 13.9.Rogue Holdings, LLC
  • 13.10.PL Developments, LLC

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14.Strategic Recommendations

15.About Us & Disclaimer

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제